Nipun Lakshitha de Silva, Elizabeth Hyams, Bonnie Grant, Paras Dixit, Rajdeep Bassi, Paul Bassett, Alexander N Comninos, Channa N Jayasena
{"title":"促性腺功能减退症男性长期生殖激素治疗后骨密度正常化的不完整证据。","authors":"Nipun Lakshitha de Silva, Elizabeth Hyams, Bonnie Grant, Paras Dixit, Rajdeep Bassi, Paul Bassett, Alexander N Comninos, Channa N Jayasena","doi":"10.1210/clinem/dgaf488","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The prevalence and severity of low bone mineral density (BMD) in hypogonadotropic hypogonadism (HH), as well as the ability of reproductive hormone treatment to normalize BMD have not been investigated in large multicenter studies.</p><p><strong>Objective: </strong>We performed a systemic review and meta-analysis of several small, observational studies to investigate the effect of reproductive hormone treatment on BMD in men with HH compared with control groups where available.</p><p><strong>Methods: </strong>We searched OVID Medline, Embase, CINAHL, SCOPUS, Web of Science, and Cochrane Library for studies reporting BMD or fractures in men with HH (congenital [CHH] or acquired). Study selection and data extraction were performed using COVIDENCE and a prespecified tool. Results were summarized using descriptive statistics. Meta-analysis compared BMD in men with HH vs healthy controls. Meta-regression assessed relationships between treatment duration and BMD Z-scores against normative population data.</p><p><strong>Results: </strong>Of the 33 eligible studies, 24 included data specific to men with HH (n = 625). Men with HH had low lumbar spine (LS) and femoral neck BMD, improving with hormonal treatment. Meta-analysis of 5 studies found lower LS BMD in men with HH vs healthy controls (SMD -5.98; 95% CI; -11.5 to -0.47). Men with CHH may have persistently low BMD despite prolonged hormonal treatment. Higher BMD in HH was associated with younger age at treatment initiation, partial HH, and higher serum testosterone and estradiol concentrations. Fracture prevalence was high in the few studies systematically studying fractures as an outcome; in other studies, fractures were seldom reported.</p><p><strong>Conclusion: </strong>Men with HH have low BMD that improves with reproductive hormone treatment. However, current evidence suggests that incomplete BMD normalization may be common despite long-term reproductive hormone treatment in men with HH, particularly those with CHH.</p>","PeriodicalId":520805,"journal":{"name":"The Journal of clinical endocrinology and metabolism","volume":" ","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism.\",\"authors\":\"Nipun Lakshitha de Silva, Elizabeth Hyams, Bonnie Grant, Paras Dixit, Rajdeep Bassi, Paul Bassett, Alexander N Comninos, Channa N Jayasena\",\"doi\":\"10.1210/clinem/dgaf488\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Context: </strong>The prevalence and severity of low bone mineral density (BMD) in hypogonadotropic hypogonadism (HH), as well as the ability of reproductive hormone treatment to normalize BMD have not been investigated in large multicenter studies.</p><p><strong>Objective: </strong>We performed a systemic review and meta-analysis of several small, observational studies to investigate the effect of reproductive hormone treatment on BMD in men with HH compared with control groups where available.</p><p><strong>Methods: </strong>We searched OVID Medline, Embase, CINAHL, SCOPUS, Web of Science, and Cochrane Library for studies reporting BMD or fractures in men with HH (congenital [CHH] or acquired). Study selection and data extraction were performed using COVIDENCE and a prespecified tool. Results were summarized using descriptive statistics. Meta-analysis compared BMD in men with HH vs healthy controls. Meta-regression assessed relationships between treatment duration and BMD Z-scores against normative population data.</p><p><strong>Results: </strong>Of the 33 eligible studies, 24 included data specific to men with HH (n = 625). Men with HH had low lumbar spine (LS) and femoral neck BMD, improving with hormonal treatment. Meta-analysis of 5 studies found lower LS BMD in men with HH vs healthy controls (SMD -5.98; 95% CI; -11.5 to -0.47). Men with CHH may have persistently low BMD despite prolonged hormonal treatment. Higher BMD in HH was associated with younger age at treatment initiation, partial HH, and higher serum testosterone and estradiol concentrations. Fracture prevalence was high in the few studies systematically studying fractures as an outcome; in other studies, fractures were seldom reported.</p><p><strong>Conclusion: </strong>Men with HH have low BMD that improves with reproductive hormone treatment. However, current evidence suggests that incomplete BMD normalization may be common despite long-term reproductive hormone treatment in men with HH, particularly those with CHH.</p>\",\"PeriodicalId\":520805,\"journal\":{\"name\":\"The Journal of clinical endocrinology and metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of clinical endocrinology and metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1210/clinem/dgaf488\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of clinical endocrinology and metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/clinem/dgaf488","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:低骨密度(BMD)在促性腺功能减退症(HH)中的患病率和严重程度,以及生殖激素治疗使BMD正常化的能力,尚未在大型多中心研究中进行调查。目的:我们对几项小型观察性研究进行了系统回顾和荟萃分析,以调查生殖激素治疗对HH男性骨密度的影响,并与对照组进行比较。方法:我们检索了OVID Medline、Embase、CINAHL、SCOPUS、Web of Science和Cochrane Library,检索了报道HH(先天性或后天性)男性骨骼肌骨骼肌缺损或骨折的研究。使用COVIDENCE和预先指定的工具进行研究选择和数据提取。结果采用描述性统计进行汇总。荟萃分析比较了HH男性与健康对照组的骨密度。meta回归评估了治疗时间和BMD z -评分与规范人群数据之间的关系。结果:在33项符合条件的研究中,24项纳入了HH男性特异性数据(n = 625)。男性HH患者有低腰椎(LS)和股骨颈骨密度,激素治疗改善。5项研究的荟萃分析发现,HH男性的LS骨密度低于健康对照组(SMD -5.98; 95% CI; -11.5至-0.47)。CHH患者尽管长期接受激素治疗,但骨密度仍可能持续偏低。HH患者较高的骨密度与治疗开始时较年轻、部分HH以及较高的血清睾酮和雌二醇浓度有关。在少数系统研究骨折作为结局的研究中,骨折患病率很高;在其他研究中,骨折很少报道。结论:HH患者骨密度低,生殖激素治疗可改善骨密度。然而,目前的证据表明,尽管长期使用生殖激素治疗HH患者,尤其是CHH患者,但骨密度不完全正常化可能很常见。
Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism.
Context: The prevalence and severity of low bone mineral density (BMD) in hypogonadotropic hypogonadism (HH), as well as the ability of reproductive hormone treatment to normalize BMD have not been investigated in large multicenter studies.
Objective: We performed a systemic review and meta-analysis of several small, observational studies to investigate the effect of reproductive hormone treatment on BMD in men with HH compared with control groups where available.
Methods: We searched OVID Medline, Embase, CINAHL, SCOPUS, Web of Science, and Cochrane Library for studies reporting BMD or fractures in men with HH (congenital [CHH] or acquired). Study selection and data extraction were performed using COVIDENCE and a prespecified tool. Results were summarized using descriptive statistics. Meta-analysis compared BMD in men with HH vs healthy controls. Meta-regression assessed relationships between treatment duration and BMD Z-scores against normative population data.
Results: Of the 33 eligible studies, 24 included data specific to men with HH (n = 625). Men with HH had low lumbar spine (LS) and femoral neck BMD, improving with hormonal treatment. Meta-analysis of 5 studies found lower LS BMD in men with HH vs healthy controls (SMD -5.98; 95% CI; -11.5 to -0.47). Men with CHH may have persistently low BMD despite prolonged hormonal treatment. Higher BMD in HH was associated with younger age at treatment initiation, partial HH, and higher serum testosterone and estradiol concentrations. Fracture prevalence was high in the few studies systematically studying fractures as an outcome; in other studies, fractures were seldom reported.
Conclusion: Men with HH have low BMD that improves with reproductive hormone treatment. However, current evidence suggests that incomplete BMD normalization may be common despite long-term reproductive hormone treatment in men with HH, particularly those with CHH.